Guilherme Pedron Formigari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guilherme Pedron Formigari has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Coraline Heron
UnivRouen Normandy, INSERM UMR1096 (EnVI Laboratory), Rouen, France
1 shared publication - Eric Camerer
Université Paris Cité, Paris centre de recherche cardiovasculaire (PARCC), Inserm U970
1 shared publication - Florea Lupu
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
1 shared publication - Gwendalyn J. Randolph
Department of Pathology and Immunology, School of Medicine, Washington University in St Louis, St Louis, USA
1 shared publication - Hong Chen
Vascular Biology Program, Boston Children’s Hospital, Boston, Massachusetts, USA
1 shared publication - Ilaria Del Gaudio
Université Paris Cité, Paris centre de recherche cardiovasculaire (PARCC), Inserm U970
1 shared publication
Latest Publications
- Open Access
- 24 June 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (9)
S1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum
Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/− mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.
- 24 June 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (9)
Open AccessS1PR1 regulates lymphatic valve development and tertiary lymphoid organ formation in the ileum
Efficient lymph flow is ensured by lymphatic valves (LVs). The mechanisms that regulate LV development are incompletely understood. Here, we show that the deletion of the GPCR sphingosine 1-phosphate receptor-1 (S1PR1) from lymphatic endothelial cells (LECs) results in fewer LVs. Interestingly, LVs that remained in the terminal ileum-draining lymphatic vessels were specifically dysfunctional. Furthermore, tertiary lymphoid organs (TLOs) formed in the terminal ileum of the mutant mice. TLOs in this location are associated with ileitis in humans and mice. However, mice lacking S1PR1 did not develop obvious characteristics of ileitis. Mechanistically, S1PR1 regulates shear stress signaling and the expression of the valve-regulatory molecules FOXC2 and connexin-37. Importantly, Foxc2+/− mice, a model for lymphedema-distichiasis syndrome, also develop TLOs in the terminal ileum. Thus, we have discovered S1PR1 as a previously unknown regulator of LV and TLO development. We also suggest that TLOs are a sign of subclinical inflammation that can form due to lymphatic disorders in the absence of ileitis.